Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Margolin

Showing results (331-340 of 406) with videos related to

Pageof 41
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2005
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancerKim A Margolin, James H Doroshow, Paul Frankel, et al.
The Journal of Experimental Medicine|June 1, 2016
Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patientAude G Chapuis, Sylvia M Lee, John A Thompson, et al.
Journal of Cancer Research and Clinical Oncology|June 8, 1999
Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trialK A Margolin, P Y Liu, J M Unger, et al.
Leukemia|July 29, 2000
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remissionA S Stein, M R O'Donnell, M L Slovak, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2000
A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine AJ W Raschko, T W Synold, W Chow, et al.
Genome Research|December 28, 2012
ATARiS: computational quantification of gene suppression phenotypes from multisample RNAi screensDiane D Shao, Aviad Tsherniak, Shuba Gopal, et al.
The American Journal of Pathology|December 8, 2004
CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumorsChi-Ming Li, Connie E Kim, Adam A Margolin, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2009
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium StudyStephen I Shibata, James H Doroshow, Paul Frankel, et al.
American Journal of Ophthalmology|May 18, 2025
Association of Glucagon-Like Peptide-1 Receptor Agonists With Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 CountriesMoiz Lakhani, Angela T H Kwan, Andrew Mihalache, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumorsE M Newman, M Carroll, S A Akman, et al.
Pageof 41

Showing results (331-340 of 406) with videos related to

Sort By:
Pageof 41
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2005
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell cancerKim A Margolin, James H Doroshow, Paul Frankel, et al.
The Journal of Experimental Medicine|June 1, 2016
Combined IL-21-primed polyclonal CTL plus CTLA4 blockade controls refractory metastatic melanoma in a patientAude G Chapuis, Sylvia M Lee, John A Thompson, et al.
Journal of Cancer Research and Clinical Oncology|June 8, 1999
Phase II trial of biochemotherapy with interferon alpha, dacarbazine, cisplatin and tamoxifen in metastatic melanoma: a Southwest Oncology Group trialK A Margolin, P Y Liu, J M Unger, et al.
Leukemia|July 29, 2000
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remissionA S Stein, M R O'Donnell, M L Slovak, et al.
Cancer Chemotherapy and Pharmacology|December 29, 2000
A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine AJ W Raschko, T W Synold, W Chow, et al.
Genome Research|December 28, 2012
ATARiS: computational quantification of gene suppression phenotypes from multisample RNAi screensDiane D Shao, Aviad Tsherniak, Shuba Gopal, et al.
The American Journal of Pathology|December 8, 2004
CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumorsChi-Ming Li, Connie E Kim, Adam A Margolin, et al.
Cancer Chemotherapy and Pharmacology|March 27, 2009
Phase I trial of GTI-2040, oxaliplatin, and capecitabine in the treatment of advanced metastatic solid tumors: a California Cancer Consortium StudyStephen I Shibata, James H Doroshow, Paul Frankel, et al.
American Journal of Ophthalmology|May 18, 2025
Association of Glucagon-Like Peptide-1 Receptor Agonists With Optic Nerve and Retinal Adverse Events: A Population-Based Observational Study Across 180 CountriesMoiz Lakhani, Angela T H Kwan, Andrew Mihalache, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1997
Pharmacokinetics and toxicity of 120-hour continuous-infusion hydroxyurea in patients with advanced solid tumorsE M Newman, M Carroll, S A Akman, et al.
Pageof 41